Lescol Side Effects
Generic name: fluvastatin
Medically reviewed by Drugs.com. Last updated on Jul 20, 2024.
Note: This document provides detailed information about Lescol Side Effects associated with fluvastatin. Some dosage forms listed on this page may not apply specifically to the brand name Lescol.
Applies to fluvastatin: oral capsule, oral tablet extended release.
Serious side effects of Lescol
Along with its needed effects, fluvastatin (the active ingredient contained in Lescol) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking fluvastatin:
More common side effects
- chills
- diarrhea
- fever
- general feeling of discomfort or illness
- joint pain
- loss of appetite
- muscle aches and pain
- nausea
- runny nose
- shivering
- sore throat
- sweating
- trouble sleeping
- unusual tiredness or weakness
- vomiting
Less common side effects
- bladder pain
- bloody or cloudy urine
- cough producing mucus
- dark-colored urine
- difficult, burning, or painful urination
- difficulty with breathing
- difficulty with moving
- difficulty with swallowing
- dizziness
- fast heartbeat
- frequent urge to urinate
- hives
- itching
- lower back or side pain
- muscle cramps, spasms, or stiffness
- muscular pain, tenderness, wasting, or weakness
- pain, swelling, or redness in the joints
- puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue
- skin rash
- tightness in the chest
Other side effects of Lescol
Some side effects of fluvastatin may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common side effects
- acid or sour stomach
- belching
- headache
- heartburn
- indigestion
- stomach discomfort, upset, or pain
Less common side effects
- bloated or full feeling
- excess air or gas in the stomach or intestines
- pain or tenderness around the eyes and cheekbones
- passing gas
- unable to sleep
For healthcare professionals
Applies to fluvastatin: oral capsule, oral tablet extended release.
General adverse events
The most frequently reported side effects were headache, dyspepsia, abdominal pain, nausea, and myalgia.[Ref]
Musculoskeletal
- Common (1% to 10%): Myalgia, arthritis, arthropathy, arthralgia, pain in extremity, back pain
- Rare (0.01% to 0.1%): Muscular weakness, myopathy
- Very rare (less than 0.01%): Rhabdomyolysis, myositis, lupus erythematosus-like syndrome
- Frequency not reported: Immune-mediated necrotizing myopathy
- Postmarketing reports: Muscle cramps, muscle spasms[Ref]
Hepatic
- Common (1% to 10%): ALT increased, AST increased
- Very rare (less than 0.01%): Hepatitis
- Postmarketing reports: Chronic active hepatitis, cholestatic jaundice, fatty change in liver, cirrhosis, fulminant hepatic necrosis, fatal hepatic failure, nonfatal hepatic failure, gamma-glutamyl transpeptidase increased, bilirubin increased[Ref]
Gastrointestinal
- Common (1% to 10%): Dyspepsia, diarrhea, abdominal pain, nausea, flatulence, tooth disorder, upper abdominal pain, constipation, gastric disorder
- Very rare (less than 0.01%): Pancreatitis
- Postmarketing reports: Vomiting[Ref]
Dermatologic
- Common (1% to 10%): Rash
- Rare (0.01% to 0.1%): Urticaria
- Very rare (less than 0.01%): Angioedema, face edema, eczema, dermatitis, bullous exanthema
- Postmarketing reports: Bullous dermatitis, alopecia, pruritus, skin nodules, skin discoloration, dry skin/mucous membranes, hair/nails changed[Ref]
Respiratory
- Very common (10% or more): Upper respiratory tract infection (16.2%)
- Common (1% to 10%): Sinusitis, bronchitis, nasopharyngitis, exertional dyspnea, pharyngitis, rhinitis, cough[Ref]
Other
- Common (1% to 10%): Influenza-like symptoms, accidental trauma, fatigue, peripheral edema, blood transaminases increased, creatine phosphokinase increased
- Uncommon (0.1% to 1%): Chest pain
- Postmarketing reports: Vertigo, alkaline phosphatase increased[Ref]
Nervous system
- Common (1% to 10%): Headache, dizziness, syncope
- Very rare (less than 0.01%): Paresthesia, dysesthesia, hypoesthesia
- Postmarketing reports: Tremor, peripheral nerve palsy, peripheral neuropathy, dysfunction of cranial nerve, alteration of taste, extra-ocular movement impaired, facial paresis, cognitive impairment, memory loss, forgetfulness, amnesia, memory impairment[Ref]
Genitourinary
- Common (1% to 10%): Urinary tract infection
- Postmarketing reports: Erectile dysfunction, gynecomastia[Ref]
Cardiovascular
- Common (1% to 10%): Atrial fibrillation, hypertension, intermittent claudication
- Very rare (less than 0.01%): Vasculitis[Ref]
Hematologic
- Very rare (less than 0.01%): Thrombocytopenia[Ref]
Renal
- Frequency not reported: Myoglobinuria, acute renal failure[Ref]
Immunologic
- Common (1% to 10%): Allergy
- Very rare (less than 0.01%): Anaphylactic reaction[Ref]
Hypersensitivity
- Rare (less than 0.1%): Hypersensitivity reaction[Ref]
An apparent hypersensitivity syndrome was reported rarely and included one or more of the following: anaphylaxis, angioedema, lupus erythematosus-like syndrome, polymyalgia rheumatica, vasculitis, purpura, thrombocytopenia, leukopenia, hemolytic anemia, positive antinuclear antibodies, erythrocyte sedimentation rate increased, eosinophilia, arthritis, arthralgia, urticaria, asthenia, photosensitivity reaction, fever, chills, flushing, malaise, dyspnea, toxic epidermal necrolysis, erythema multiforme, and Stevens-Johnson syndrome.[Ref]
Oncologic
- Postmarketing reports: Hepatoma[Ref]
Endocrine
- Postmarketing reports: Thyroid function abnormal[Ref]
Psychiatric
- Common (1% to 10%): Insomnia
- Postmarketing reports: Anxiety, depression, psychic disturbances, loss of libido, confusion[Ref]
Metabolic
- Frequency not reported: HbA1c increased, serum glucose increased
- Postmarketing reports: Anorexia[Ref]
Ocular
- Postmarketing reports: Cataracts progressed, lens opacity, ophthalmoplegia[Ref]
References
1. Cerner Multum, Inc. "UK Summary of Product Characteristics."
2. Cerner Multum, Inc. "Australian Product Information."
3. (2001) "Product Information. Lescol (fluvastatin)." Novartis Pharmaceuticals
Frequently asked questions
More about Lescol (fluvastatin)
- Check interactions
- Compare alternatives
- Reviews (2)
- Drug images
- Latest FDA alerts (3)
- Dosage information
- During pregnancy
- Drug class: statins
- Breastfeeding
- En español
Patient resources
Professional resources
Other formulations
Related treatment guides
Further information
Lescol side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.